IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-451) (VH (HOMO SAPIENS IGHV3-23*01 (90.8%)-(IGHD)-IGHJ4*01 (100%)) CDR-IMGT (8.8.14) (26-33.51-58.97-110) (1-121)-HOMO SAPIENS IGHG1*01, NG1M1, G1M17 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (122-451)), (224-215')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-216') (V-LAMBDA (HOMO SAPIENSIGLV1-47*02 (92.9%)-IGLJ2*01 (100%)) CDR-IMGT (8.3.11) (26-33.51-53.90-100) (1'-110')-HOMO SAPIENS IGLC3*03 (100%) (111'-216')); DIMER (230-230'':233-233'')-BISDISULFID
Solid Tumor
ISU Abxis Co., Ltd.monoclonal_antibodyPhase 1Dormant
C
36/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 59/ 100
Competitive context
928 Active assets in the Solid Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PANITUMUMAB Astellas Pharma Inc | Phase 2 | BBB |
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM Sanofi | Phase 4 | BB |
Inno-206 The First Affiliated Hospital of Soochow University | Phase 2/3 | BB |
DINITROGEN MONOXIDE Medical College of Wisconsin | Phase 4 | BB |
Glycopyrrolate Medical College of Wisconsin | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →